Peripheral Vascular Devices – Market Insights – Latin America

A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost constraints in the region’s publicly funded health care systems continue to hinder adoption of premium-priced DCBs and DES and limit the pace of revenue expansion.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Latin America from 2019 through 2032.

Uptake of drug-eluting technologies will drive growth in the market.

To what degree will DES and DCBs be adopted in Latin America over the forecast period? How will adoption affect use of other PV stents or PTA balloons, respectively?

What are current perceptions of paclitaxel-coated devices in Latin America?

What impact will the recent FDA letter concerning paclitaxel-based devices have on device choice in Latin America?

What clinical outcomes have been generated in clinical trials for drug-eluting technologies?

Competitors are developing DES and DCBs that do not use paclitaxel.

What companies are developing these products?

What impact will the approval of such products have on use of existing devices?

M&A activities or partnerships involving key competitors may lead to shifts in market shares going forward.

Which acquisitions have occurred, and how will these acquisitions impact competitor performance in the future?

How are competitors leveraging product portfolio acquisitions to expand their product offerings?

Endovascular treatment of PVD is increasing in Latin America.

Which country has the highest penetration of endovascular procedures?

What factors influence the selection of PV stents or PTA balloons for endovascular procedures among the Latin American countries covered?

Which country will see the highest procedural and market revenue growth?

Most segments in the Latin American PV device market continue to be dominated by large international manufacturers.

Which companies are the leading competitors in each of the PV device segments?

What competitive strategies can firms use to maintain and/or improve their competitive positions going forward?

Table of contents

Peripheral Vascular Devices - Market Insights - Latin America

Pankhil Gandhi, PharmD

Pankhil Gandhi is an analyst within the Cardiovascular Medtech Insights team at Clarivate, specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.

Contact sales Login to access report

Back to all Medtech Insights reports